SCHEMBL10914136

SCHEMBL10914136

CCOC(=O)OC1=NN(CC)C2=C(C(=O)OC2)C1c1ccccc1Cl

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.39
TSHR P16473 1/20 0.39
ALDH1A1 P00352 3/20 0.38
KDM4E B2RXH2 1/20 0.38
BCHE P06276 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
ALOX12 P18054 1/20 0.36
CYP2C19 P33261 1/20 0.36
PYGL P06737 5/20 0.36
PYGM P11217 5/20 0.36
LMNA P02545 1/20 0.36
ACHE P22303 1/20 0.35
CACNA1C Q13936 2/20 0.35
CACNA1F O60840 1/20 0.35
CACNA1D Q01668 1/20 0.35
CACNA1S Q13698 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
HTR1A P08908 2/20 0.34
ADRA2A P08913 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10649530 0.81 PYGL (0.39) POLBTSHRALDH1A1KDM4EBCHE
SCHEMBL9865516 0.75 PYGL (0.48) POLBTSHRALDH1A1KDM4ECYP3A4
SCHEMBL10653759 0.74 CYP3A4 (0.39) POLBTSHRALDH1A1KDM4ECYP3A4
SCHEMBL10967987 0.73 ALDH1A1 (0.44) POLBTSHRALDH1A1KDM4ECYP3A4
SCHEMBL10648966 0.73 ALDH1A1 (0.56) POLBTSHRALDH1A1KDM4ECYP3A4
SCHEMBL11016561 0.73 TSHR (0.41) POLBTSHRALDH1A1KDM4EBCHE
SCHEMBL10659301 0.72 PYGL (0.52) ALDH1A1PYGLPYGM
SCHEMBL9865957 0.71 PYGL (0.44) POLBTSHRALDH1A1KDM4ECYP3A4
SCHEMBL9829022 0.71 PYGL (0.48) PYGLPYGM
SCHEMBL9865258 0.70 CYP3A4 (0.47) POLBTSHRALDH1A1KDM4ECYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0173205-A2 1,4-Dihydropyridazine derivatives, process for their preparation and their use in medicaments BAYER AG (DE) 1986-03-05 EP disclosed